FY2026 EPS Estimates for EverQuote Reduced by Zacks Research

Key Points

• Zacks Research lowered its FY2026 EPS estimate for EverQuote to $1.86 (from $1.89) and has a Hold rating, while projecting FY2027 EPS of $2.22.
• EverQuote's most recent quarter (Feb. 23) beat expectations with $1.54 EPS vs. $0.35 expected and revenue of $195.3M, up 32.3% year‑over‑year, with a 14.34% net margin.
• Analyst sentiment is mixed-to-positive (six Buys, two Holds) with a consensus price target of $23.83, while the stock trades near $15.09 and its 200‑day SMA is $21.42.

EverQuote, Inc. (NASDAQ:EVER - Free Report) - Analysts at Zacks Research cut their FY2026 earnings estimates for EverQuote in a research report issued on Thursday, April 9th. Zacks Research analyst Team now expects that the company will post earnings per share of $1.86 for the year, down from their prior forecast of $1.89. Zacks Research currently has a "Hold" rating on the stock. The consensus estimate for EverQuote's current full-year earnings is $0.72 per share. Zacks Research also issued estimates for EverQuote's FY2027 earnings at $2.22 EPS.

EverQuote (NASDAQ:EVER - Get Free Report) last released its quarterly earnings results on Monday, February 23rd. The company reported $1.54 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $1.19. EverQuote had a net margin of 14.34% and a return on equity of 57.65%. The company had revenue of $195.32 million for the quarter, compared to analyst estimates of $176.82 million. During the same quarter last year, the firm posted $0.33 earnings per share. The company's quarterly revenue was up 32.3% compared to the same quarter last year.

EVER has been the topic of a number of other reports. Wall Street Zen lowered EverQuote from a "strong-buy" rating to a "buy" rating in a research note on Saturday, April 4th. Craig Hallum reiterated a "buy" rating and issued a $20.00 price objective on shares of EverQuote in a research note on Tuesday, February 24th. Raymond James Financial reiterated an "outperform" rating and issued a $18.00 price objective on shares of EverQuote in a research note on Tuesday, February 17th. Needham & Company LLC dropped their target price on shares of EverQuote from $40.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday, February 24th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of EverQuote in a research report on Thursday, January 22nd. Six analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, EverQuote has an average rating of "Moderate Buy" and a consensus price target of $23.83.

EverQuote Stock Performance

EverQuote stock opened at $15.09 on Monday. The business's 50-day simple moving average is $16.01 and its 200-day simple moving average is $21.42. The firm has a market capitalization of $543.69 million, a PE ratio of 5.72 and a beta of 0.62. EverQuote has a 52 week low of $13.93 and a 52 week high of $28.73.

Institutional Investors Weigh In On EverQuote

Several institutional investors and hedge funds have recently bought and sold shares of the business. Invesco Ltd. increased its holdings in EverQuote by 31.6% in the 4th quarter. Invesco Ltd. now owns 49,143 shares of the company's stock valued at $1,327,000 after buying an additional 11,808 shares during the period. Mercer Global Advisors Inc. ADV increased its holdings in EverQuote by 40.0% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 13,343 shares of the company's stock valued at $360,000 after buying an additional 3,813 shares during the period. NewEdge Advisors LLC increased its holdings in EverQuote by 484.3% in the 4th quarter. NewEdge Advisors LLC now owns 13,223 shares of the company's stock valued at $357,000 after buying an additional 10,960 shares during the period. Zacks Investment Management increased its holdings in EverQuote by 1.2% in the 4th quarter. Zacks Investment Management now owns 66,281 shares of the company's stock valued at $1,790,000 after buying an additional 782 shares during the period. Finally, nVerses Capital LLC bought a new stake in EverQuote in the 4th quarter valued at $265,000. Institutional investors own 91.54% of the company's stock.

Insider Activity

In related news, CAO Jon Ayotte sold 1,730 shares of the business's stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $15.56, for a total transaction of $26,918.80. Following the transaction, the chief accounting officer directly owned 86,202 shares in the company, valued at $1,341,303.12. The trade was a 1.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Jayme Mendal sold 14,360 shares of the business's stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $14.98, for a total value of $215,112.80. Following the transaction, the chief executive officer owned 541,777 shares in the company, valued at $8,115,819.46. This represents a 2.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 31,785 shares of company stock worth $608,623 over the last 90 days. Corporate insiders own 25.52% of the company's stock.

EverQuote Company Profile

EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.

The company's core business centers on a quote-comparison engine for personal auto, home, and health insurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.